ADAM VOGEL to Cisplatin
This is a "connection" page, showing publications ADAM VOGEL has written about Cisplatin.
Connection Strength
0.036
-
Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER). Ann Oncol. 2020 02; 31(2):228-235.
Score: 0.036